Newsletter

Click here to join
our newsletter.

Financial Information

ASX Filing.

Date Price sens. Headline pages PDF
22/12/2017   Change of Director's Interest Notice - Russell Howard 5 PDF
21/12/2017   Investor Update 11 PDF
04/12/2017   Change of Director's Interest Notice - Mr Voigt 4 PDF
04/12/2017   Change of Director's Interest Notice - Mr Chamberlain 3 PDF
04/12/2017   Appendix 3B 19 PDF
28/11/2017   Prima BioMed company name changed to Immutep 1 PDF
22/11/2017   Final Director's Interest Notice 2 PDF
22/11/2017   Final Director's Interest Notice 2 PDF
22/11/2017 ! European patent grant for IMP321 in cancer 2 PDF
20/11/2017   Prima changes its name to Immutep Ltd 2 PDF
17/11/2017   Results of Meeting 2 PDF
17/11/2017   2017 AGM CEO Presentation 26 PDF
17/11/2017   2017 AGM Chairman's Address 3 PDF
15/11/2017   Pre-IND meeting with the FDA 2 PDF
09/11/2017   SITC 2017 Poster Presentation 3 PDF
01/11/2017   World Immunotherapy Congress 2017 Presentation 2 PDF
20/10/2017   Warrants Cleansing Prospectuses 98 PDF
20/10/2017   Dr Triebel presenting at World Immunotherapy Congress 2 PDF

 

SEC Filing.

Date Filing Description Link
2017-12-26 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-17-378237 (34 Act) Size: 64 KB
PDF
2017-12-13 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-17-367609 (34 Act) Size: 31 KB
PDF
2017-12-05 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-17-360727 (34 Act) Size: 253 KB
PDF
2017-12-05 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-17-360727 (34 Act) Size: 253 KB
PDF
2017-12-05 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-17-360727 (34 Act) Size: 253 KB
PDF
2017-12-01 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-357745 (34 Act) Size: 393 KB PDF
2017-12-01 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-357745 (34 Act) Size: 393 KB PDF
2017-11-24 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-351219 (34 Act) Size: 45 KB PDF
2017-11-24 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-351219 (34 Act) Size: 45 KB PDF
2017-11-22 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-349885 (34 Act) Size: 35 KB PDF
2017-11-21 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-348286 (34 Act) Size: 35 KB PDF
2017-11-20 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-347626 (34 Act) Size: 6 MB PDF
2017-11-20 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-347626 (34 Act) Size: 6 MB PDF
2017-11-20 6-K Documents Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-347625 (34 Act) Size: 51 KB PDF
2017-11-16 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-344407 (34 Act) Size: 31 KB PDF
2017-11-09 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-339045 (34 Act) Size: 35 KB PDF
2017-11-01 EFFECT Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-328236 (34 Act) Size: 34 KB PDF
2017-10-20 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-315493 (34 Act) Size: 53 KB PDF
2017-10-20 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-17-315468 (34 Act) Size: 337 KB PDF
2017-10-19 F-3 Registration statement by foreign private issuers Acc-no: 0001193125-17-313995 (33 Act) Size: 505 KB PDF